New Approach to Treating ‘Cold’ Neuroblastoma Developed

OPACC
2 minutes ago
1 min read

Researchers at Children’s Hospital of Philadelphia (CHOP) have developed a potentially new treatment strategy aimed at immunologically “cold” tumors by restoring their ability to present antigens to the immune system.

Comments

New Approach to Treating ‘Cold’ Neuroblastoma Developed

Adolescent Cancer Survivors Age Faster Than Their Peers

Guiding the attack: CXCR3 leads CAR T cells to pediatric brain tumors

Accelerated Brain Aging Tied to Neurocognition

Machine learning identifies statin and phenothiazine combo for neuroblastoma treatment

PTSD, Depression, Anxiety in Childhood Cancer Survivors, Parents

Adults ignorant of medical history

Study Tracks Risk of Meningiomas in Childhood Cancer Survivors

Genetic insights advance understanding of pediatric thyroid cancer

Combination therapy shows promise to treat a rare, catastrophic pediatric brain cancer

Recent Posts

New Approach to Treating ‘Cold’ Neuroblastoma Developed

Comments

New Approach to Treating ‘Cold’ Neuroblastoma Developed

Adolescent Cancer Survivors Age Faster Than Their Peers

Guiding the attack: CXCR3 leads CAR T cells to pediatric brain tumors

Accelerated Brain Aging Tied to Neurocognition

Machine learning identifies statin and phenothiazine combo for neuroblastoma treatment

PTSD, Depression, Anxiety in Childhood Cancer Survivors, Parents

Adults ignorant of medical history

Study Tracks Risk of Meningiomas in Childhood Cancer Survivors

Genetic insights advance understanding of pediatric thyroid cancer

Combination therapy shows promise to treat a rare, catastrophic pediatric brain cancer

Archive

Search By Tags